MRC1 and melanoma: Additionally, high levels of DCIR expression by circulating DCIR+ cDC2s predicted better clinical outcome, whereas high levels of CD206 expression by circulating CD206+ cDC2s were associated with worse OS in melanoma patients (Supplementary Figure 9A).